CXCR4 antagonists for wound healing and re-epithelialization
US9034814B2 · kind B2 · utility
2Cited by
5References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 21, 2006 |
| Grant date | May 19, 2015 |
| Priority date | — |
| Expiry date | Jul 30, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel uses for CXCR4 antagonists, including specifically peptides of the T-140 family, in the treatment of skin burns and other injuries. The invention further provides methods for increasing epithelialization in a subject in need thereof, and for preventing or inhibiting fibrosis and excessive scar formation, using peptide inhibitors of the T-140 family as well as other CXCR4 antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.